Trends and disparity in zoster vaccine uptake in a managed care population.
OBJECTIVE
Zoster vaccine is recommended for prevention of herpes zoster among adults aged 60 years and older. We examined the zoster vaccination rates during 2007-2011 and assessed association with age, sex, race/ethnicity, neighborhood income and education attainment in eligible adults at Kaiser Permanente Southern California, a managed care organization in the US.


METHODS
We calculated annual zoster vaccination rate among members ≥60 years without documented contraindications. Multivariable logistic regression was performed to examine factors associated with zoster vaccine uptake in an open cohort of 819,466 adults.


RESULTS
The zoster vaccination rates increased annually in all groups and the overall rate reached 21.7% in 2011 (P-trend<0.001). Coverage was highest among individuals aged 65-74 years, who were female and non-Hispanic White. In the adjusted analysis, odds of vaccination decreased by age. Females (odds ratio [OR]=1.19, 95% confidence interval [CI]=1.17-1.20) and those who lived in neighborhoods with higher education attainment were more likely to be vaccinated (>75% vs. <50% adults with some college education: OR=1.76, 95% CI=1.73-1.80). Compared to Whites, non-Hispanic Blacks and Hispanics were less likely to receive the vaccine (non-Hispanic Blacks: OR=0.56, 95% CI=0.55-0.58; Hispanics: OR=0.59, 95% CI=0.58-0.60).


CONCLUSIONS
The zoster vaccine coverage is higher in this insured population than previously reported in the US general population, but it remains low. Significant racial/ethnic disparity was observed and worsened even among individuals with relatively equal access to zoster vaccination.
Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.
Rulin C
RC
Hechter
Sara Y
SY
Tartof
Steven J
SJ
Jacobsen
Ning
N
Smith
Hung Fu
HF
Tseng
D000368:Aged; D000369:Aged, 80 and over; D002140:California; D015331:Cohort Studies; D004363:Drug Utilization / Q000639:trends*; D005260:Female; D006562:Herpes Zoster / Q000517:prevention & control*; D053061:Herpes Zoster Vaccine / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008329:Managed Care Programs; D008875:Middle Aged
D053061:Herpes Zoster Vaccine
Disparity; Herpes zoster; Vaccination